Over‐expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer - Concepedia

Concepedia

Publication | Closed Access

Over‐expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer

51

Citations

16

References

2011

Year

Mingzhu Yin, Cong Li, Xia Li, Ge Lou, Bing Miao, Xiaodong Liu, Fanling Meng, Haiyu Zhang, Xiuwei Chen, Meng Sun,

Journal of Surgical Oncology

Abstract

LAPTM4B over-expression is an independent factor in stages III-IV epithelial ovarian carcinoma prognosis and chemotherapy resistance, and it may be an important potential biomarker.

References

	Year	Citations

Page 1